Start with patient needs
We focus on needs that existing treatments do not adequately address and seek approaches suited to the biology of each disease.
ABOUT CURACLE
A new path to treatment through vascular science
Curacle is a biopharmaceutical company developing new treatment options for intractable and age-related diseases through a distinctive approach to vascular normalization.
Building on our expertise in vascular research, we develop oral small molecules and antibody-based biologics. We discover candidates with a focus on retinal, kidney and thrombotic diseases, advancing them through clinical studies in Korea and abroad and global partnerships.
OUR GROWTH
Growing into a global drug development company
- 2016
Founded
Drug discovery rooted in vascular research
- 2021
KOSDAQ listing
Technology-special listing with AA and A technology assessment ratings
- Clinical development
Evaluating efficacy and safety
Assessing candidates in clinical studies in Korea and abroad
- Global partnerships
Licensing & co-development
Advancing further development with global partners
Our approach to drug development
Advance through scientific evidence
We evaluate mechanism of action, efficacy and safety step by step, using the findings to inform each stage of development.
Accelerate through collaboration
We combine our research capabilities with partners’ technologies and expertise to advance drug development and global commercialization.
MISSION
Translate insights from vascular research into differentiated medicines that expand treatment options for patients with intractable and age-related diseases.
VISION
Become a global leader in restoring microvascular function and shape a new standard of care for chronic diseases.